New Search

Julie Poulin, MD

Julie Poulin, MD, PhD, MBA

  • Medical Director of West Ridge Center
  • Medical Director of TMS Center

Specialties:

Psychiatry
  • Member of
    Rutland Regional Medical Team

Credentials

Profile

Gender:

Female

Languages:

English and French

Service Line

Experience

Year began practicing: 2013

Year joined staff: 2013

Year began practicing in specialty: 2013

Education

1996-1998, Laval University, Psychology 1999-2001, University of Montreal, Master's in Biomedical Science 2018-2021, University of Massachusetts Amherst Isenberg School of Management, Masters of Business Administration

Medical School

2001-2006, University of Montreal, Doctor of Medicine 2001-2009, University of Montreal, Doctorate in Biomedical Sciences

Residency

2009-2013, University of Pittsburgh Medical Center, Psychiatry

Professional Memberships

  • American Psychiatric Association
  • Vermont Psychiatric Association
  • American Medical Association
  • American Association of Physician Leadership
  • Academy of Brain Stimulation
  • Clinical TMS Society

Board Certifications

American Board of Psychiatry & Neurology

About Me

Julie Poulin, MD, PhD, MBA, treats patients in both the inpatient and outpatient settings at Rutland Regional, which includes the Inpatient Unit, South Wing, TMS Center, and the West Ridge Center. 

A graduate of Psychology from the University Laval in Quebec, Canada, Dr. Poulin went on to the University of Montreal where she earned a Masters in Science for Biomedical Sciences, her Medical Doctorate in 2006, and in 2010, a PhD in Biomedical Sciences. Dr. Poulin completed four years of Residency in Psychiatry at the University of Pittsburgh Medical Center at the Western Psychiatric Institute and Clinic in Pittsburgh, PA. 

There is more evidence that with proper treatment, patients with severe mental illnesses do improve, and become well enough to live and function normally in their community.
— Julie Poulin, MD, PhD, MBA 

Selected Publications:

  1. Poulin J. (2019) Depression: Knowing the Signs and How to Get Help. Health eCooking®, Baldwin Publishing, Inc.
  2. Poulin J. (2018) Brain Mechanisms of Health and Happiness Grand Rounds RRMC
  3. Hall E., Poulin J. (2018) Benzodiazepine use in Primary Care Practice RRMC  
  4. Poulin, J (2013) . Magnetoencephalography and movies of brain activation in schizophrenia. UPMC Grand Rounds, Pittsburgh, PA.
  5. Poulin J, Kim WJ, Germain A. (2012) Resilience through sleep. Sleep disorders and therapy. 1: 2.
  6. Poulin J, Chouinard S, Pampoulova T, Lecomte Y, Stip E, Godbout R. (2010). Sleep habits in middle-aged, non­-hospitalized men and women with schizophrenia: a comparison with healthy controls. Psychiatry Research, 179(3):274-278
  7. Poulin J., Stip E., Godbout R. (2008). REM sleep EEG spectral analysis in patients with first-episode schizophrenia. Journal of Psychiatric research, 42(13):1086-1093.
  8. Forest, G., Poulin, J., Lussier, I., Stip, E., Godbout, R. (2007). Attention and non-REM sleep in neuroleptic-naive persons with schizophrenia and control participants. Psychiatry research, 149: 33-40.
  9. Chouinard, S., Stip, E., Poulin, J., Melun, J.P., Godbout, R., Guillem, F., Cohen, H. (2007). Rivastigmine treatment as an add-on to antipsychotics in patients with schizophrenia and cognitive deficits. Current medical research and opinion, 23(3):575-83.
  10. Guillem, F., Chouinard, S., Poulin, J., Godbout, R., Lalonde, P., Melun P., Bentaleb L.A., Stip, E. (2006). Are cholinergic enhancers beneficial for memory in schizophrenia? An event-related potentials (ERPs) study of rivastigmine add-on therapy in a crossover trial. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 30; 934-945
  11. Chouinard, S., Poulin, J., Stip E., Godbout, R. (2004). Sleep in Untreated Patients with Schizophrenia: A Meta­ Analysis. Schizophrenia Bulletin, 30(4): 957-967.
  12. Poulin, J., Daoust, A.-M., Forest, G., Stip, E., et Godbout, R. (2003). Sleep architecture and its clinical correlates in first-episode and neuroleptic-naive patients with schizophrenia. Schizophrenia Research 62, 147-153.

Locations